Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2016

Trasino SE, Tang X-, Jessurun J, Gudas LJ. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease. J Mol Med (Berl). 2016;94(10):1143-1151.

Moscat J, Karin M, Diaz-Meco MT. p62 in Cancer: Signaling Adaptor Beyond Autophagy. Cell. 2016;167(3):606-609.

Wells J, Ozerdem U, Scognamiglio T, Hoda SA. Invasive Mammary Adenoid Cystic Carcinoma with an Intraductal Component. Breast J. 2016;22(2):233-4.

Lemon JA, Aksenov V, Samigullina R, Aksenov S, Rodgers WH, Rollo CD, et al. A multi-ingredient dietary supplement abolishes large-scale brain cell loss, improves sensory function, and prevents neuronal atrophy in aging mice. Environ Mol Mutagen. 2016;57(5):382-404.

Jain M, Robinson BD, Aggarwal A, Shevchuk MM, Scherr DS, Mukherjee S. Multiphoton microscopy for rapid histopathological evaluation of kidney tumours. BJU Int. 2016;118(1):118-26.

Signoretti S, Di Marcotullio L, Richardson A, Ramaswamy S, Isaac B, Rue M, et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest. 2016;126(11):4387.

Martin P, Maddocks K, Leonard JP, Ruan J, Goy A, Wagner-Johnston N, et al. Postibrutinib outcomes in patients with mantle cell lymphoma. Blood. 2016;127(12):1559-63.

Jia S, Liu Z, Zhang S, Liu P, Zhang L, Lee SH, et al. Corrigendum: Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis. Nature. 2016;533(7602):278.

Santo EE, Paik J. FOXO3a & haematopoietic stem cells: Goodbye PI3K, hello SIRT1? Cell Cycle. 2016;15(7):879-80.

Khani F, Diolombi ML, Khattar P, Huang W, Fallon JT, Epstein JI, et al. Benign and Malignant Brenner Tumors Show an Absence of TERT Promoter Mutations That Are Commonly Present in Urothelial Carcinoma. Am J Surg Pathol. 2016;40(9):1291-5.